| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $127.5M | -16.1% |
| Cost of Revenue | $104.8M | -14.2% |
| Gross Profit | $22.6M | -23.9% |
| R&D Expense | $363K | -53.4% |
| SG&A Expense | $30.0M | -19.0% |
| Operating Income | -$37.8M | -172.4% |
| Pre-tax Income | -$38.0M | -182.0% |
| Income Tax | $1.2M | -6.1% |
| Net Income | -$39.2M |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.4M | -30.6% |
| Accounts Receivable | $39.7M | -33.6% |
| Inventory | $6.6M | +4.4% |
| Current Assets | $72.9M | -28.9% |
| Total Assets | $102.2M | -16.7% |
| Current Liabilities | $72.5M | -15.6% |
| Total Liabilities | $101.6M | +15.2% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.4M | +59.7% |
| Capital Expenditures | $1.1M | -44.1% |
| Investing Cash Flow | -$5.2M | -273.8% |
| Financing Cash Flow | $1.9M | -81.6% |
| Free Cash Flow | -$8.5M | +58.2% |
| -165.7% |
| EPS (Basic) | -$0.69 | -155.6% |
| EPS (Diluted) | -$0.69 | -155.6% |
| Stockholders' Equity |
| $605K |
| -98.2% |